C. Edwin Garner Email and Phone Number
C. Edwin Garner work email
- Valid
- Valid
C. Edwin Garner personal email
- Valid
I am a scientist with broad experience in the design and support of drug discovery research programs and mechanistic toxicology. Strength in the integration of chemistry, pharmacology, metabolism, kinetics, and toxicology knowledge to guide decisions in drug discovery and development.My goal is to assist small to medium size pharmaceutical companies in discovery and development of small molecules and biologicals. I am available to companies which need an experienced preclinical team member but do not desire to commit to a full time position.General Capabilities•Demonstrated ability to build scientific consortia across disparate disciplines with both domestic and international research institutions to address complex scientific problems.•Broad experiences in both basic and applied research environments. •Experience in cross discipline international technical operations (EU, Japan, China, India). •Significant experience in report, grant and proposal writing.•Excellent writing, presentation and communication skills.•Builds consensus, draws others together around ideas. Recognized for Technical Expertise in Following Methodologies:Drug Metabolism and PharmacokineticsDesign and conduct of single and repeat dose rodent, canine, and non-human primate pharmacokinetic, disposition and metabolism studies.Extensive capabilities in the use of in vitro methodologies for mechanistic investigation of biotransformation, pharmacology and toxicology.Transporter and metabolism studies using Caco-2, isolated perfused rat kidney, isolated perfused rat liver, Ussing chamber, and in situ perfused intestine models.In vivo and in vitro Drug-Drug interaction studies.Identification of metabolites.Use of transgenic animals to investigate metabolic and toxicological endpoints.Whole Body Autoradiography (WBA) studies. Modeling and SimulationPK, PBPK, PK/PD modeling. Interspecies scaling of pharmacokinetics to select clinical doses.
Resero Analytics
View- Website:
- reseroanalytics.com
- Employees:
- 6
-
Vice President, Modeling And SimulationResero AnalyticsPlacitas, Nm, Us -
PrincipalMammoth Preclinical Consulting, Llc Jul 2019 - PresentPlacitas, Nm, Us -
Vice President, Drug Development Salzman Group, Inc.Salzman Group, Inc. Jan 2017 - Jan 2020
-
Sr. Director, Drug DevelopmentLuria Scientific Industries, Ltd. Aug 2015 - Jul 2019Luria provides expert consultation and study conduct in all aspects of pharmaceutical discovery and development. Preclinical drug discovery pharmacology, toxicology, ADME, medicinal chemistry, process chemistry, CMC, clinical study design and monitoring.Luriasci.com
-
Sr. Director, Pharmaceutical SciencesRadikal Therapeutics Inc. May 2015 - Jul 2019Radikal Therapeutics is a multi-national biotechnology firm focused on the discovery and development of transformative pharmaceuticals with specific focus on pulmonary injury. -
PrincipalOso Corredor Scientific Consulting Oct 2013 - May 2015Consultant in pharmacokinetics, xenobiotic metabolism, ADME, biochemical toxicology.
-
Director, Metabolism And PharmacokineticsLovelace Respiratory Research Institute Oct 2011 - Oct 2013Albuquerque, Nm, Us -
Director Of Drug Metabolism And PharmacokineticsInstitute For Pharmaceutical Discovery Sep 2010 - Oct 2011
-
Principal ScientistAstrazeneca Sep 2006 - Aug 2010Cambridge, Cambridgeshire, GbDrug Metabolism and PharmacokineticsCancer and Infection Discovery Research -
Sr. Research PharmacokineticistRti International Jan 2003 - Sep 2006Research Triangle Park, Nc, UsSupervises staff of scientists in pharmacokinetics, metabolism, disposition and efficacy studies of pharmaceuticals and other chemicals. Operations conducted within GLP regulations. Designs protocols and guides preclinical strategy for both internal and client drug discovery and development programs. Conducts disposition/metabolism studies using radioisotopes and stable isotopes. Pharmacokinetic and pharmacodynamic modeling. Use of perfused organ models to conduct drug transporter/drug-drug interaction studies. Budgeting and client interactions.Major Responsibilities:Principal Investigator- Over 50 PK/ADME studies for pharmaceutical clients. Principal Investigator-Pharmacology/Pharmacocokinetics Drug Discovery Program for Spinal Muscular Atrophy Therapeutics, National Institute for Neurodegenerative Disease and Stroke Toxicokinetic Task Leader for National Toxicology Program. -
Associate Principal ScientistSchering-Plough Jan 2001 - Jan 2003Rahway, New Jersey, UsProvided PK, toxicokinetic (TK), PD, toxicodynamic (TD) data analysis to preclinical Good Laboratory Practice (GLP)-compliant Drug Safety and Development programs. Designed dosing regimens in toxicology and drug interaction studies and addressed PK/PD/TK issues. Investigated PK/Absorption, Distribution, Metabolism, and Elimination (ADME) contribution to mechanisms of drug toxicity. Constructed PK/TK and TK/TD models in Kinetica, WinNonlin, and other software. Principal contributor to SPRI Human Clinical Pharmacokinetic Prediction Task Force. Acted as preclinical Compound Director contributing to development of drug candidates and preparation of regulatory submission documents -
Research ScientistDupont Pharmaceuticals Jan 1999 - Jan 2001UsDesigned and executed PK, TK, PD, TD, and preclinical drug interaction studies to investigate PK/ADME contribution to mechanisms of drug toxicity and efficacy. Use of whole body autoradiogaphy and other isotopic methods to investigate disposition of xenobiotics. Constructed PK/TK models. Supervised and lead lab personnel in providing PK/PD/TK support of drug candidates for preclinical studies in accordance with GLP regulations. Conducted in situ and isolated perfused tissue studies to elucidate transporter mediated clearance mechanisms. Prepared and reviewed regulatory submissions. Represented DMPK in development Project Teams -
Research FellowNational Institute Of Environmental Health Sciences Dec 1994 - Jan 1999Laboratory of Pharmacology and Chemistry. Constructed compartmental and physiologically based (PB) PK Developed whole tissue skin culture methods for study of cutaneous metabolism of xenobiotics. Performed syntheses of metabolites; structural ID by NMR & MS. Michaelis-Menten enzyme kinetic assays Isolation of metabolites. Small animal surgeries.
C. Edwin Garner Skills
C. Edwin Garner Education Details
-
North Carolina State UniversityToxicology -
Barton CollegeMathematics
Frequently Asked Questions about C. Edwin Garner
What company does C. Edwin Garner work for?
C. Edwin Garner works for Resero Analytics
What is C. Edwin Garner's role at the current company?
C. Edwin Garner's current role is Vice President, Modeling and Simulation.
What is C. Edwin Garner's email address?
C. Edwin Garner's email address is ha****@****hoo.com
What schools did C. Edwin Garner attend?
C. Edwin Garner attended North Carolina State University, Barton College.
What skills is C. Edwin Garner known for?
C. Edwin Garner has skills like Drug Discovery, Drug Metabolism, Pharmacokinetics, Adme, Toxicology, Pharmacology, Pharmaceutical Industry, In Vitro, In Vivo, Dmpk, Clinical Development, Drug Development.
Who are C. Edwin Garner's colleagues?
C. Edwin Garner's colleagues are Akash Khare.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial